Background We report a case of recurrent cytomegalovirus (CMV) retinitis in an HIV-
negative patient with CD4+ T lymphocytopenia. Methods Case report. Results A 41-year-old …

Background and Methods: We performed a randomized controlled clinical trial to assess the
safety and efficacy of a 1 μg/h ganciclovir implant for the treatment of newly diagnosed …

• Cytomegalovirus retinopathy lesions in patients with the acquired immunodeficiency
syndrome may continue to enlarge despite ganciclovir sodium treatment. In an historical …

Cytomegalovirus (CMV) resistance to ganciclovir occurs via mutations in the UL97 gene.
CMV DNA, from vitreous and blood specimens and from culture isolates from 87 patients …

* BACKGROUND AND OBJECTIVE: An intravitreal device administering ganciclovir in a
sustained-release fashion has been developed for site-specific therapy of cytomegalovirus …

CYTOMEGALOVIRUS (CMV) infections are a major cause of morbidity and mortality among
immunocompromised patients, especially recipients of bone marrow and solid-organ …

Purpose: The authors report their surgical experience replacing empty ganciclovir implants
in patients with acquired immune deficiency syndrome (AIDS)-related cytomegalovirus …

Objective: To determine the effect of highly active antiretroviral therapy (HAART) on
cytomegalovirus (CMV) viraemia and retinitis in patients at high risk of disease. Design …

Forty-four patients with acquired immune deficiency syndrome with cytomegalovirus (CMV)
retinitis (64 eyes) intolerant of or refusing systemic antiviral therapy received 710 intravitreal …

Valganciclovir, an oral prodrug of the anti-cytomegalovirus (CMV) agent ganciclovir, was
evaluated in a single-arm open-label safety study. AIDS patients (median CD4 lymphocyte …